Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Gastrointestinal motility modulation" refers to the regulation of the coordinated contractions and relaxations that move contents through the gastrointestinal tract. This is not a single molecular target or receptor but rather an integrated physiological process controlled by multiple systems: - **Neural control** involves both intrinsic networks like the enteric nervous system (ENS) and extrinsic input from the autonomic nervous system (ANS) and central nervous system (CNS). The ENS contains excitatory cholinergic neurons that promote contraction via acetylcholine, as well as inhibitory nitrergic neurons that induce relaxation via nitric oxide synthase activity. Disruption in these neuronal populations can lead to disorders such as slow-transit constipation[1][2]. - **Hormonal control** includes gut peptides such as serotonin, gastrin, secretin, somatostatin, vasoactive intestinal peptide (VIP), and especially motilin—which stimulates migrating motor complexes during fasting periods. These hormones act on various receptors throughout the gut wall to modulate contractile patterns according to digestive needs[3]. - **Cellular elements** include interstitial cells of Cajal—pacemaker cells generating rhythmic electrical slow waves—and PDGFRα-positive cells which modulate smooth muscle inhibition through purinergic signaling pathways. Loss or dysfunction of these cell types impairs normal peristalsis leading to dysmotility syndromes like chronic constipation or pseudo-obstruction[1]. Because "gastrointestinal motility modulation" describes an entire regulatory network rather than one discrete druggable entity or protein structure, it does not fit standard definitions for canonical therapeutic targets such as receptors or enzymes. If you are seeking structured information about specific molecules involved in GI motility modulation—such as 5-hydroxytryptamine receptor 4 ("5‑HT₄ receptor"), muscarinic acetylcholine receptors ("M₃ receptor"), interstitial cell markers ("KIT"), etc.—please specify which component you wish detailed information about. In summary: "Gastrointestinal motility modulation" is not itself a canonical molecular target but encompasses numerous interacting proteins/cells/receptors/hormones responsible for regulating gut movement.[1][2][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal motility modulation (GI motility modulation).